BOSTON, July 31, 2024 /PRNewswire/ — Recently, Shanghai Medicilon Inc. (“Medicilon”) and Jiangsu Hengrui Pharmaceuticals Co., Ltd. (“Hengrui Pharma”) reached a strategic collaboration agreement. The cooperative efforts will focus on preclinical evaluation of new drug modalities,…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.